Multiple Sclerosis Trial, Recruiting NCT07318129 Sponsor: Glostrup University Hospital, Copenhagen Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07318129
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 65 years (both women and men)
  • People who have been diagnosed with relapsing-remitting multiple sclerosis (a form of MS where symptoms come and go) using a specific set of diagnostic standards called the 2017 McDonald criteria or a newer version
  • People who are already receiving regular treatment and check-ups for their MS
  • People who can speak and read Danish
  • People who are considered by their doctor to be physically and mentally well enough to take part in the study

Who may not be able to join:

  • People who currently have an active cancer
  • People who have been diagnosed with Crohn's disease or ulcerative colitis (conditions affecting the digestive system)
  • People who have other health conditions that the trial team considers relevant (confirm with trial site)
  • People who have previously had a stem cell transplant involving blood-forming cells
  • People who are currently taking, or have previously taken, non-MS medications that the trial team considers relevant (confirm with trial site)
  • People who are pregnant or breastfeeding
  • People who are unable to have an MRI scan, including those with:
    • Severe claustrophobia (strong fear of enclosed spaces)
    • Certain implants or metal objects in the body, such as pacemakers, artificial heart valves, middle ear prostheses, insulin pumps, metal fragments in the eyes, surgical metal clips, or certain tubes and shunts

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jette Lautrup Frederiksen, MD, dr.med, professor, Copenhagen University Hospital, Rigshospitalet-Glostrup

Phone: +4538633041

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Glostrup University Hospital, Copenhagen
Registry
ClinicalTrials.gov
Start date
26 January 2026
Est. completion
15 July 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

No evidence of disease activity (NEDA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov